Microdialysis is widely used in animal models and human patients to monitor and assess the extracellular neurochemistry of the living, intact brain. It has made significant contributions to the study of the neurochemistry of behavior, CNS pathology, drug discovery, and clinical care. Despite its many beneficial attributes, microdialysis suffers from an overlooked drawback in that implanting the probes causes a penetration injury to the tissues being analyzed. The penetration injury results in opening of the blood brain barrier, ischemia of the tissue surrounding the probe, and the activation of astrocytes that eventually engulf the probe track in a glial scar. The penetration injury affects the outcome of microdialysis experiments, i.e. the results reflect the neurochemical attributes of the injured, rather than normal, tissues. The goal of the research proposed here is to establish the feasibility of ameliorating the penetration injury and its impact on microdialysis results by the combined use of a powerful anti-inflammatory drug, dexamethasone, and a novel mitochondrially-targeted electron and radical scavenging cytoprotective agent. The outcome of this research will have a lasting and significant impact on the several branches of neuroscience that involve the insertion of devices into brain tissues, including microdialysis, electrochemical sensors, and neuroprosthetic devices such as deep brain stimulators and neuron recordings arrays.

Public Health Relevance

Microdialysis is highly relevant to public health as a tool used to investigate the role of brain chemistry in behavior, CNS disease, drug discovery, and clinical care. Although the technique has many beneficial attributes, it is also true that the probes damage and disturb the brain tissue that is analyzed. Ameliorating this damage and isruption will improve the use of microdialysis by increasing the physiological relevance of the results it provides.

Agency
National Institute of Health (NIH)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21NS081744-02
Application #
8657494
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Bellgowan, Patrick S F
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Gu, Hui; Varner, Erika L; Groskreutz, Stephen R et al. (2015) In Vivo Monitoring of Dopamine by Microdialysis with 1 min Temporal Resolution Using Online Capillary Liquid Chromatography with Electrochemical Detection. Anal Chem 87:6088-94
Wipf, Peter; Eyer, Benjamin R; Yamaguchi, Yukihiro et al. (2015) Synthesis of anti-inflammatory α-and β-linked acetamidopyranosides as inhibitors of toll-like receptor 4 (TLR4). Tetrahedron Lett 56:3097-3100
Nesbitt, Kathryn M; Varner, Erika L; Jaquins-Gerstl, Andrea et al. (2015) Microdialysis in the rat striatum: effects of 24 h dexamethasone retrodialysis on evoked dopamine release and penetration injury. ACS Chem Neurosci 6:163-73
Jaquins-Gerstl, Andrea; Michael, Adrian C (2015) A review of the effects of FSCV and microdialysis measurements on dopamine release in the surrounding tissue. Analyst 140:3696-708
Zhang, Jing; Jaquins-Gerstl, Andrea; Nesbitt, Kathryn M et al. (2013) In vivo monitoring of serotonin in the striatum of freely moving rats with one minute temporal resolution by online microdialysis-capillary high-performance liquid chromatography at elevated temperature and pressure. Anal Chem 85:9889-97
Nesbitt, Kathryn M; Jaquins-Gerstl, Andrea; Skoda, Erin M et al. (2013) Pharmacological mitigation of tissue damage during brain microdialysis. Anal Chem 85:8173-9